Lack of Influence of Pregnancy on the Prognosis of Survivors of Thyroid Cancer

  • Budak, Adnan (Tepecik Education and Research Hospital, Department of Gynecology and Obstetrics) ;
  • Gulhan, Ibrahim (Tepecik Education and Research Hospital, Department of Gynecology and Obstetrics) ;
  • Aldemir, Onur Suleyman (Tepecik Education and Research Hospital, Department of Gynecology and Obstetrics) ;
  • Ileri, Alper (Tepecik Education and Research Hospital, Department of Gynecology and Obstetrics) ;
  • Tekin, Emine (Ege University, Department of Nuclear Medicine) ;
  • Ozeren, Mehmet (Tepecik Education and Research Hospital, Department of Gynecology and Obstetrics)
  • Published : 2013.11.30


Objective: The aim of this study is to investigate the influence of pregnancy on prognosis of thyroid cancer. Methods: A total of 72 patients aged between 15-45 years who underwent total or subtotal thyroidectomy and subsequently radioablation were followed up under suppression. Individuals who had term pregnancies after diagnosis of cancer (group 1, n: 36) and who were non-pregnant (group 2, n:36) were included in the study. Both groups were compared in terms of scintigraphic relapse and metastasis, ultrasonographic relapse, stage change of lympadenopathy at the beginning and at the end of the study. Results: Relapse was detected in 4 out of 36 pregnant patients (11.1%) and in 5 out of 36 non-pregnant patients (13.9%) with no significant difference between groups (p=1.00). Pathologic lymphadenopathy was detected in 2 out of 36 pregnant patients (5.6%) and in 2 out of 36 non-pregnant patients (5.6%) (p=1.00), and metastasis in 3 (8.3%) and in 1 (2.8%), respectively (p=0.61). While stage change was detected in only one pregnant patient (2.8%), and none of the non-pregnant again there was no significant difference (p=1.00). Conclusions: We conclude that pregnancy does not have an influence on prognosis of thyroid cancer.


Pregnancy;thyroid cancer;prognosis


  1. Balenovi. A, Vlasi. M, Sonicki Z, Bodor D, Kusi. Z (2006). Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma. Coll Antropol, 30, 743-8.
  2. Cabezon CA, Carrizo LC, Costanzo PR (2013). Evolution of differentiated thyroid cancer during pregnancy in a community University Hospital in Buenos Aires, Argentina. Arq Bras Endocrinol Metabol, 57, 307-11.
  3. Casara D, Rubello D, Saladini G, et al (1993). Pregnancy after high therapeutic doses of iodine-131 in differentiated thyroid cancer: potential risks and recommendations. Eur J Nucl Med, 20, 192-4.
  4. Collins BJ, Chiappetta G, Schneider AB, et al (2002). RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions. J Clin Endocrinol Metab, 87, 3941-6.
  5. Gibelli B, Zamperini P, Proh M, Giugliano G (2011). Management and follow-up of thyroid cancer in pregnant women. Acta Otorhinolaryngol Ital, 31, 358-65.
  6. Hirsch D, Levy S, Tsvetov G, et al (2010). Impact of pregnancy on outcome and prognosis of survivors of papillary thyroid cancer. Thyroid, 20, 1179-85.
  7. Hundahl SA, Cady B, Cunningham MP, et al (2000). Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German thyroid cancer study group. An American college of surgeons commission on cancer patient care evaluation study. Cancer, 89, 202-17.<202::AID-CNCR27>3.0.CO;2-A
  8. Jameson JL, Weetman AP (2001). Thyroid cancer. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds). Harrison's principles of internal medicine. 15th ed., 2079-83.
  9. Monroy-Lozano BE, Hurtado-Lopez LM, Zaldivar-Ramirez FR, Basurto-Kuba E (2001). Clinical behavior of thyroid papillary cancer in pregnancy: optimal time for its treatment. Ginecol Obstet Mex, 69, 359-62.
  10. Pomorski L, Bartos M, Narebski J (2000). Pregnancy following operative and complementary treatment of thyroid cancer. Zentralbl Gynakol, 122, 383-6.
  11. Schneider AB, Ron E (2000). Carcinoma of follicular epithelium. In: Braverman LE, Utiger RD (eds). Werner and Ingbar's the thyroid. 8th ed. Philadelphia: Lippincott Williams and Wilkins, 878-86.
  12. Yasmeen S, Cress R, Romano PS, et al (2005). Thyroid cancer in pregnancy. Int J Gynaecol Obstet, 91, 15-20.

Cited by

  1. Baseline Stimulated Thyroglobulin Level as a Good Predictor of Successful Ablation after Adjuvant Radioiodine Treatment for Differentiated Thyroid Cancers vol.15, pp.15, 2014,
  2. Association between p16 Promoter Methylation and Thyroid Cancer Risk: A Meta-analysis vol.16, pp.16, 2015,